Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tongluo, specifically referring to the **Tongluo Zhitong** (通络止痛) series of preparations developed by the **Gansu Provincial Hospital of Traditional Chinese Medicine**, is a Traditional Chinese Medicine (TCM) treatment used for chronic musculoskeletal pain. The most prominent form is the **Tongluo Zhitong Liquid**, an oral hospital preparation indicated for conditions such as chronic low back pain, sciatica, lumbar disc herniation, lumbar muscle strain, knee arthritis, and cervical spondylosis. The formulation is designed to "dredge the meridians" and "unblock the collaterals" to improve blood circulation and alleviate pain. Pharmacologically, these preparations are thought to exert anti-inflammatory and analgesic effects by inhibiting pro-inflammatory cytokines like TNF-α, IL-1β, and IL-6, and modulating inflammatory enzymes such as COX-2. It is a registered hospital preparation (院内制剂) widely utilized within the Gansu provincial medical system.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tongluo zhitong liquid.